9 Minutes for Colonoscopy Withdrawal

NCT03399045 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1027

Last updated 2020-01-02

No results posted yet for this study

Summary

A withdrawal time of at least 6 minutes has been considered to be necessary to guarantee the adenoma detection rate and the critical quality criterion of colonoscopy. However, several large observational investigations demonstrated that 9 minutes will be in favor of higher adenoma detection rate and lower risk of interval colorectal cancer, when compared with 6-minute withdrawal. Meanwhile, a few studies also indicated that no significant benefit were observed in longer withdrawal time. Up to now, no randomized controlled trials have been conducted to give a definitive conclusion. Therefore, we performed a multicenter, prospective, randomized Controlled trial to compare adenoma detection rate of 6-minute and 9-minute withdrawal in colonoscopy.

Conditions

  • Colon Polyps
  • Colorectal Adenomas

Interventions

PROCEDURE

9-minute withdrawal

Patients in 9-minute withdrawal group will be carefully observed for 9 minutes during the colonoscopy withdraw

PROCEDURE

6-minute withdrawal

Patients in 6-minute withdrawal group will be carefully observed for 6 minutes during the colonoscopy withdraw

Sponsors & Collaborators

  • No.85 Hospital, Changning, Shanghai, China

    collaborator OTHER
  • The Second Clinical Medical College of Jinan University

    collaborator OTHER
  • Qinghai People's Hospital

    collaborator OTHER
  • Shaanxi Provincial People's Hospital

    collaborator OTHER
  • Shanghai 8th People's Hospital

    collaborator OTHER
  • Yantaishan Hospital of Yantai City

    collaborator UNKNOWN
  • First Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • Changzhi People's Hospital

    collaborator OTHER
  • Ningbo Medical Center Li Huili Eastern Hospital

    collaborator UNKNOWN
  • The Third People's Hospital of Datong

    collaborator UNKNOWN
  • The First Affiliated Hospital of the Medical College, Shihezi University

    collaborator UNKNOWN
  • The First Affiliated Hospital of Dalian Medical University

    collaborator OTHER
  • Seventh Medical Center of PLA Army General Hospital

    collaborator OTHER
  • Changhai Hospital

    lead OTHER

Principal Investigators

  • Li Zhaoshen, M.D · Changhai Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-20
Primary Completion
2019-07-01
Completion
2019-07-06

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03399045 on ClinicalTrials.gov